Fortis Healthcare share news, announcements and annual reports
NSE: FORTISBSE: 532843Healthcare ServicesMid Cap
Fortis Healthcare Limited · Formerly Fortis Healthcare (India) · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 2007
Last close ₹759.50up ₹23.00 (3.12%)BSE ₹758.00
Share price at the NSE close on 28 Oct 2026. Previous close ₹736.50.
28 Oct: open ₹734.90, high ₹762.90, low ₹726.85
52-week range of traded prices to 28 Oct 2026
₹704.95Low, 23 Oct 2026₹1,067.70High, 28 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹57,339 Cr156th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 54.72
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 5.79
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.13%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 11.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 12.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.28
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 14,44,496
Fortis Healthcare has 1,295 announcements on record, routine notices left out; 3 in the 30 days to 28 Oct 2026, the latest on 12 Oct 2026.
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Fortis Healthcare quarterly results
Aug6Thu
The board met on 6 Aug 2026 to consider financial results
Notice filed 30 Jul 2026
Fortis Healthcare annual reports, presentations and earnings calls
The company's own documents, latest first.Fortis Healthcare financials, year by year
Annual reports17
- Annual report, year to Mar 202617 Jul 2026
- Annual report, year to Mar 202514 Jul 2025
- Annual report, year to Mar 202411 Jul 2024
- Annual report, year to Mar 20238 Jul 2023, a zip file
- Annual report, year to Mar 20228 Jul 2022, a zip file
12 earlier reports
- Annual report, year to Mar 20217 Jul 2021, a zip file
- Annual report, year to Mar 20207 Aug 2020, a zip file
- Annual report, year to Mar 201918 Mar 2020, a zip file
- Annual report, year to Mar 201829 Oct 2018, a zip file
- Annual report, year to Mar 201727 Sep 2017, a zip file
- Annual report, year to Mar 201628 Sep 2016, a zip file
- Annual report, year to Mar 201527 Aug 2015, a zip file
- Annual report, year to Mar 201430 Aug 2014, a zip file
- Annual report, year to Mar 20133 Sep 2013, a zip file
- Annual report, year to Mar 201217 Sep 2012, a zip file
- Annual report, year to Mar 20117 Sep 2011, a zip file
- Annual report, year to Mar 201013 Jun 2011, a zip file
Investor presentations29
- Investor Presentation6 Aug 2026
- Investor Presentation22 May 2026
- Investor Presentation13 Feb 2026
- Presentation8 Jan 2026
- Investor Presentation11 Nov 2025
24 earlier presentations
- Investor Presentation6 Aug 2025
- Investor Presentation20 May 2025
- Investor Presentation7 Feb 2025
- Investor Presentation8 Nov 2024
- Investor Presentation6 Aug 2024
- Investor Presentation28 May 2024
- Investor Presentation23 May 2024
- Investor Presentation7 Feb 2024
- Investor Presentation10 Nov 2023
- Investor Presentation4 Aug 2023
- Investor Presentation23 May 2023
- Investor Presentation17 Jun 2020
- Investor Presentation for the financial results of the Company for the quarter and period ended on December 31, 2019.14 Feb 2020
- Investor PresentationPursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosures Requirement) Regulation, 2015, please find enclosed Investors Presentation on financial results for quarter and period ended December 31, 2018. This is for your information and records please.14 Feb 2019
- 'Update to Outcome of the Board Meeting dated August 14, 2018 '.This is with reference to our letter ref. no. FHL/SEC/STEX/RR/2018-19 dated August 14, 2018, regarding submission of Outcome of Board Meeting held on August 14, 2018. We would like to submit that there was an inadvertent typographical error in Press Release attached with the Outcome of Board Meeting. The details of which is as follows:On Page 1 of the Press Release under the heading Key Segments Financial Highlights for Q1FY19, the revised extract is as follows: - Diagnostic Business EBITDA of Rs. 40.5 Cr with a margin of 18.7%A copy of the Revised Press Release issued in this regard is attached herewith. Further, please also find attached Investors Presentation.You are kindly requested to take the same on record.14 Aug 2018, a zip file
- Investor PresentationThis is with reference to our letter ref. no. FHL/SEC/STEX/RR/2018-19 dated June 27, 2018 captioned Outcome of the Adjourned Board Meeting dated June 26, 2018, please find attached Investor Presentation for your reference and records.You are kindly requested to take the same on record27 Jun 2018, a zip file
- Investor PresentationPlease find enclosed the Investors Presentation on financial Statements for the Quarter ended on September 30, 2017 and December 31, 2017 pursuant to Regulation 30, Schedule III, Part A (15) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.You are requested to take the same on your record1 Mar 2018, a zip file
- Investor Presentation5 Aug 2017, a zip file
- Investor Presentation31 May 2017, a zip file
- Investor Presentation15 Feb 2017, a zip file
- Investor Presentation11 Nov 2016, a zip file
- Presentation on financial Statements for the quarter ended on June 30, 2016 .5 Aug 2016, a zip file
- Presentation on financial Statements for the quarter and period ended on March 31, 2016.26 May 2016, a zip file
- Presentation on Financial Results made to Analysts and Institutional Investors.5 Feb 2016, a zip file
Earnings calls37
- Transcript of Investors / Analysts meet held on Friday, September 4, 2026, on the recent developments10 Sep 2026
- Link of Recording4 Sep 2026
- Transcript11 Aug 2026
- Link of Recording7 Aug 2026
- Transcript29 May 2026
32 earlier call documents
- Link of Recording25 May 2026
- Transcript20 Feb 2026
- Link of Recording16 Feb 2026
- Transcript17 Nov 2025
- Link of Recording12 Nov 2025
- Transcript11 Aug 2025
- Link of Recording7 Aug 2025
- Transcript26 May 2025
- Link of Recording21 May 2025
- Transcript14 Feb 2025
- Transcript14 Feb 2025
- Audio recording of the investors / analysts meet held on February 10,2025 to discuss the Company s un-audited financial results for the quarter and period endedDecember 31, 2024 is available on the website of the Company i.e.https://www.fortishealthcare.com/investor/investor%20presentations%20&%20transcripts/audio%20recording%20of%20q3%20fy25%20earnings%20call%20-%20february%20202510 Feb 2025
- Transcript13 Nov 2024
- Link of Recording9 Nov 2024
- Transcript12 Aug 2024
- Link of Recording7 Aug 2024
- Transcript28 May 2024
- Link of Recording26 May 2024
- Transcript and the link of audio recording of Investors / Analysts meet held on February 8, 2024 to discuss the Company s un-audited financial results for the quarter and period ended December 31, 2023 and the same is available on the website of the Company i.e. Audio recording Link and recording Link10 Feb 2024
- Transcript15 Nov 2023
- Link of Recording11 Nov 2023
- Link of Recording7 Aug 2023
- Transcript26 May 2023
- Link of Recording25 May 2023
- Transcript16 Feb 2023
- Link of Recording14 Feb 2023
- Transcript of the investors / analysts meet held on November 14, 2022 to discuss the Company's un-audited financial results for the quarter and period ended September 30, 2022. Further, the said transcript is also available on the website of the Company i.e. https://www.fortishealthcare.com/investors.18 Nov 2022
- Audio recording of the investors / analysts meet held on November 14, 2022 to discuss the Company's un-audited financial results for the quarter and period ended September 30, 2022 is available on the website of the Company i.e. https://www.fortishealthcare.com/investors.14 Nov 2022
- Transcript of the investors / analysts meet held on August 8, 2022 to discuss the Company's un-audited financial results for the quarter ended June 30, 2022. Further, the said transcript is also available on the website of the Company i.e. https://www.fortishealthcare.com/investors.This is for your kind information and record.11 Aug 2022
- Audio recording of the investors / analysts meet held on August 8, 2022 to discuss the Company's un-audited financial results for the quarter ended June 30, 2022 is available on the website of the Company i.e. https://www.fortishealthcare.com/investors.This is for your kind information and record.9 Aug 2022
- Transcript of the investors / analysts meet held on May 26, 2022 to discuss the Company's Audited Financial Results for the quarter and year ended March 31, 2022. Further, the said transcript is also available on the website of the Company i.e. https://www.fortishealthcare.com/investors.This is for your kind information and records.31 May 2022
- Audio recording of the investors / analysts meet held yesterday to discuss the Company's Audited Financial Results for the quarter and year ended March 31, 2022 is available on the website of the Company i.e. https://www.fortishealthcare.com/investors.This is for your kind information and records.27 May 2022
Fortis Healthcare merger and demerger filings
Filings about a merger, demerger or scheme of arrangement, latest first.
Filings4
- Scheme of merger by absorption between wholly owned subsidiaries16 Jan 2026
- Effective date of Scheme of Arrangement1 Sep 2025
- Scheme of Arrangement31 Jul 2025
- Intimation for withdrawal of the Composite Scheme of Arrangement and Amalgamation14 Jun 2018, a zip file
Fortis Healthcare share news and announcements
Newest first. Page 1 of 26.
Oct 2026
12 Oct · Updates
Sep 2026
29 Sep · General Updates
16 Sep · General Updates
15 Sep · Analysts
11 Sep
9 Sep · Analysts
9 Sep · Analysts
9 Sep · Analysts
9 Sep · Analysts
4 Sep · Analysts
1 Sep · Analysts
Aug 2026
24 Aug
11 Aug · Meeting
11 Aug · Meeting
7 Aug · Analysts
6 Aug · Results
5 Aug
Jul 2026
31 Jul · Analysts
30 Jul · Analysts
17 Jul · Corporate action
17 Jul
17 Jul · Updates
17 Jul · Meeting
Jun 2026
May 2026
25 May · Analysts
22 May · General Updates
22 May · Results
15 May · Analysts
Apr 2026
23 Apr
22 Apr · Analysts
Mar 2026
How the price met the news
The latest 30. The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts). Delivery against usual in the glossary
- 7 Aug 2026Resultsup 3.82%+3.9 pts vs Nifty 500market median −0.7% · five sessions −1.5% (−1.2 pts vs Nifty 500) · volume 3.6× usual · delivery −14.0 pts against usual · The announcement
- 25 May 2026Resultsup 1.04%−0.2 pts vs Nifty 500market median −0.7% · five sessions −3.2% (−2.3 pts vs Nifty 500) · volume 1.4× usual · delivery −15.3 pts against usual · The announcement
- 16 Feb 2026Resultsdown 0.11%−0.8 pts vs Nifty 500market median −0.7% · five sessions +0.5% (+0.1 pts vs Nifty 500) · volume 1.2× usual · delivery −5.3 pts against usual · The announcement
- 6 Jan 2026Credit ratingup 3.23%+3.4 pts vs Nifty 500market median 0.0% · five sessions −2.4% (−0.1 pts vs Nifty 500) · volume 2.0× usual · delivery +2.4 pts against usual · The announcement
- 12 Nov 2025Resultsdown 1.77%−2.4 pts vs Nifty 500market median −0.7% · five sessions −6.0% (−6.6 pts vs Nifty 500) · volume 3.3× usual · delivery −17.4 pts against usual · The announcement
- 2 Sep 2025Credit ratingup 0.55%+0.5 pts vs Nifty 500market median 0.0% · five sessions +2.0% (+1.2 pts vs Nifty 500) · volume 0.4× usual · delivery −10.3 pts against usual · The announcement
- 7 Aug 2025Resultsup 3.01%+2.9 pts vs Nifty 500market median −0.7% · five sessions +10.2% (+10.1 pts vs Nifty 500) · volume 6.4× usual · delivery −17.2 pts against usual · The announcement
- 21 May 2025Resultsdown 1.05%−1.7 pts vs Nifty 500market median −0.7% · five sessions +3.8% (+2.8 pts vs Nifty 500) · volume 1.2× usual · delivery +16.2 pts against usual · The announcement
- 10 Feb 2025Resultsdown 3.55%−2.3 pts vs Nifty 500market median −0.7% · five sessions −7.1% (−2.4 pts vs Nifty 500) · volume 1.6× usual · delivery +2.2 pts against usual · The announcement
- 11 Nov 2024Resultsup 0.52%+0.8 pts vs Nifty 500market median −0.7% · five sessions +4.5% (+7.8 pts vs Nifty 500) · volume 0.6× usual · delivery −8.0 pts against usual · The announcement
20 earlier announcements
- 1 Oct 2024Credit ratingup 0.12%0.0 pts vs Nifty 500market median 0.0% · five sessions −2.9% (+0.1 pts vs Nifty 500) · volume 1.0× usual · delivery +4.9 pts against usual · The announcement
- 7 Aug 2024Resultsdown 2.14%−4.0 pts vs Nifty 500market median −0.7% · five sessions +4.1% (+2.9 pts vs Nifty 500) · volume 2.0× usual · delivery +9.2 pts against usual · The announcement
- 7 Aug 2024Board or managers changeddown 2.14%−4.0 pts vs Nifty 500market median 0.0% · five sessions +4.1% (+2.9 pts vs Nifty 500) · volume 2.0× usual · delivery +9.2 pts against usual · The announcement
- 12 Jun 2024Board or managers changeddown 0.27%−0.8 pts vs Nifty 500market median 0.0% · five sessions +4.3% (+2.6 pts vs Nifty 500) · volume 0.5× usual · delivery +4.5 pts against usual · The announcement
- 24 May 2024Dividenddown 1.48%−1.5 pts vs Nifty 500market median 0.0% · five sessions −2.5% (−0.4 pts vs Nifty 500) · volume 2.3× usual · delivery −18.3 pts against usual · The announcement
- 14 Mar 2024Board or managers changedup 4.34%+3.0 pts vs Nifty 500market median 0.0% · five sessions +3.8% (+3.8 pts vs Nifty 500) · volume 0.6× usual · delivery −2.1 pts against usual · The announcement
- 12 Feb 2024Board or managers changeddown 0.79%+0.6 pts vs Nifty 500market median 0.0% · five sessions −0.2% (−1.2 pts vs Nifty 500) · volume 0.5× usual · delivery −12.0 pts against usual · The announcement
- 8 Feb 2024Resultsdown 2.54%−1.9 pts vs Nifty 500market median −0.7% · five sessions −5.9% (−5.0 pts vs Nifty 500) · volume 1.5× usual · delivery +10.4 pts against usual · The announcement
- 15 Jan 2024Board or managers changeddown 1.66%−2.4 pts vs Nifty 500market median 0.0% · five sessions +0.7% (+1.5 pts vs Nifty 500) · volume 1.3× usual · delivery +23.4 pts against usual · The announcement
- 12 Nov 2023Resultsdown 0.28%−0.9 pts vs Nifty 500market median −0.7% · five sessions −0.9% (−2.9 pts vs Nifty 500) · volume 0.4× usual · delivery −12.5 pts against usual · The announcement
- 9 Oct 2023Board or managers changedup 0.81%+1.8 pts vs Nifty 500market median 0.0% · five sessions +3.2% (+2.7 pts vs Nifty 500) · volume 1.0× usual · delivery +6.5 pts against usual · The announcement
- 4 Sep 2023Board or managers changedup 1.99%+1.4 pts vs Nifty 500market median 0.0% · five sessions +4.6% (+2.2 pts vs Nifty 500) · volume 0.4× usual · delivery −13.2 pts against usual · The announcement
- 1 Sep 2023Board or managers changeddown 2.19%−3.1 pts vs Nifty 500market median 0.0% · five sessions +1.4% (−1.4 pts vs Nifty 500) · volume 0.5× usual · delivery −8.6 pts against usual · The announcement
- 7 Aug 2023Resultsdown 4.31%−4.7 pts vs Nifty 500market median −0.7% · five sessions −6.1% (−5.9 pts vs Nifty 500) · volume 2.7× usual · delivery −4.0 pts against usual · The announcement
- 24 Jul 2023Credit ratingup 0.25%+0.5 pts vs Nifty 500market median 0.0% · five sessions 0.0% (−0.2 pts vs Nifty 500) · volume 1.2× usual · delivery +19.3 pts against usual · The announcement
- 24 May 2023Dividenddown 0.48%−0.3 pts vs Nifty 500market median 0.0% · five sessions −2.8% (−4.4 pts vs Nifty 500) · volume 2.8× usual · delivery −20.7 pts against usual · The announcement
- 29 Mar 2023Board or managers changedup 1.16%+0.2 pts vs Nifty 500market median 0.0% · five sessions −2.4% (−6.2 pts vs Nifty 500) · volume 0.6× usual · delivery −3.2 pts against usual · The announcement
- 24 Feb 2023Board or managers changeddown 0.61%−0.4 pts vs Nifty 500market median 0.0% · five sessions +0.5% (+1.1 pts vs Nifty 500) · volume 0.4× usual · delivery −7.4 pts against usual · The announcement
- 13 Feb 2023Resultsdown 3.71%−2.9 pts vs Nifty 500market median −0.7% · five sessions −5.0% (−4.9 pts vs Nifty 500) · volume 1.3× usual · delivery −14.0 pts against usual · The announcement
- 2 Feb 2023Credit ratingup 0.07%+0.1 pts vs Nifty 500market median 0.0% · five sessions +0.7% (−0.5 pts vs Nifty 500) · volume 1.4× usual · delivery +12.7 pts against usual · The announcement
Fortis Healthcare results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.